Opioid addiction is a serious problem in the United States, with approximately 2.1 million people suffering from an opioid use disorder in 2018.1 Opioid withdrawal symptoms can be debilitating and can include anxiety, nausea, vomiting, diarrhea, muscle aches, and insomnia.2 Until recently, there were limited options for treating opioid withdrawal symptoms, but the approval of Lucemyra (lofexidine hydrochloride) in 2018 has revolutionized the treatment of opioid withdrawal symptoms.
Lucemyra is an oral medication approved by the U.S. Food and Drug Administration (FDA) for the mitigation of opioid withdrawal symptoms.3 It is a selective alpha-2-adrenergic receptor agonist that works by reducing the release of norepinephrine, a neurotransmitter that is involved in the body’s response to stress.4 By blocking the release of norepinephrine, Lucemyra reduces the symptoms of opioid withdrawal.
Lucemyra is typically used in conjunction with other medications and behavioral therapies to treat opioid withdrawal symptoms. It is administered as an oral solution and is typically taken twice a day for up to 14 days.5 The dosage of Lucemyra is based on the patient’s age, weight, and severity of symptoms.6
The most significant benefit of Lucemyra is its ability to reduce the severity of opioid withdrawal symptoms.7 Studies have shown that it can reduce the severity of symptoms such as anxiety, nausea, vomiting, diarrhea, muscle aches, and insomnia.8 It also has fewer side effects than other medications used to treat opioid withdrawal symptoms, such as clonidine.9 In addition to its effectiveness in treating opioid withdrawal symptoms, Lucemyra has also been shown to be effective in helping patients maintain abstinence from opioids.10 Studies have found that patients taking Lucemyra were more likely to remain abstinent from opioids for longer periods of time than those taking a placebo.11 This is an important benefit of Lucemyra, as it can help patients stay in recovery and avoid relapse.
Lucemyra is a revolutionary medication that has had a significant impact on the treatment of opioid withdrawal symptoms. It is effective in reducing the severity of symptoms and has fewer side effects than other medications used to treat opioid withdrawal. In addition, it has been shown to be effective in helping patients maintain abstinence from opioids. For these reasons, Lucemyra is an important tool in treating opioid addiction and helping patients stay in recovery.
1.
Studies have shown that physical activity prevents cancer in patients who have been treated for cancer in the past.
2.
Glioblastoma treatment breakthrough shows promise
3.
Expert Q&A: A Drug Holiday for Metastatic Prostate Cancer?
4.
Marstacimab Gets FDA Nod for Hemophilia A or B Without Inhibitors
5.
Small-Town Patients Face Big Hurdles as Rural Hospitals Cut Cancer Care
1.
The Latest Research on Wiskott Aldrich Syndrome
2.
Uncovering the Hidden Signs: How to Recognize the Early Symptoms of Colon Cancer
3.
Transplant Oncology and Anti-Cancer Immunosuppressants: The Evolution of a Paradigm in Cancer Care
4.
Preventing Heparin Induced Thrombocytopenia: Tips for Successful Anticoagulation Therapy
5.
Bispecific Antibodies in Hematologic Malignancies: Mechanisms, Clinical Applications, and Future Directions
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part IV
2.
Current Scenario of Cancer- Final Discussion on the Importance of Genomic Testing & Advancement in Diagnosis and Treatment
3.
Efficient Management of First line ALK-rearranged NSCLC - Part V
4.
Daratumumab, Lenalidomide, and Dexamethasone (DRd) Versus Lenalidomide and Dexamethasone (Rd) in MRD Negativity
5.
Effect of Pablociclib in Endocrine Resistant Patients - A Panel Discussion
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation